Recent content from Joe Carlson
They are rethinking using paclitaxel-coated stents, balloons following report.
Company said some devices temporarily lose ability to pace the heart.
Researchers in December flagged higher patient death rates, but device companies have questioned the findings.
A new $1.3 million economic-development initiative called MedTech Bridge is trying to capitalize on Denmark's strengths.
The ruling pertains only to 61 Bair Hugger suits filed in state courts by Minn. residents.
Local firm is the latest to try to shake up the $100 billion clinical lab business
One shot while in car, another at bus stop.
The companies say their data don't show safety risks that researchers have cited in a published analysis.
Gains in fast-growing niches led the way.
The EyeBox can detect dysfunction in the brain by tracking eye movements.
The microbiome company is the fourth with U roots to be acquired in the past 18 months.
The two companies have been working for years on a system to create details of 3-D surgical plans.
Hundreds gather to honor Medtronic founder as visionary, philanthropist.
Serious neck injuries in patients who received the Infuse surgical implant weren't reported to regulators for years.
Dozens of peer-reviewed papers on the Bair Hugger's safety profile have been published, some critical, some supportive.
As lawsuits pile up, 3M defends Bair Hugger against its own worst critic: the inventor.
The three cases all involved schemes to promote sales of medical devices made by ev3 and Covidien, before Medtronic acquired the companies in 2015.
Gordy C. Parkhurst was denied many of the things in early life that come to define us as adults: an education, a family, a normal…
Company uses Mayo data to teach digital tool to detect heart problems.
Omar Ishrak said firm's focus moving forward is to "invent and disrupt" the med-tech market.
Medtronic has agreed to pay a $54.5 million class-action settlement to investors to resolve allegations that a heart-pump company it acquired in 2016, HeartWare, repeatedly…
The company added the device in hopes of expanding participation.
James E. Hengen of Chanhassen allegedly peaked into his wife's work papers and made trades off the information. He is also accused of tipping off others.
Devices are OK to sell in Europe, but approval in U.S. is elusive.
Heraeus cited growth in neuromodulation as key in deal to pick up Evergreen Medical.
The company saw revenue increase nearly 9 percent in the third quarter.
The new probe eliminates the risk of overheating during use with MRI scanner.
Earl Bakken invented the pacemaker in Minneapolis and started Medtronic in 1949.
Revamped Abbott Labs device is seen as an option for cardiac patients who are unlikely to get transplants.
Medtronic implantable pump dispenses tiny doses of pain medication.
After meeting Wall Street quarterly expectations, company looks to 2019.
The Minneapolis company is developing a new type of defibrillation device.
Big-name speakers, large crowd gather at first Manova Global Summit on the Future of Health to think about innovation.
The device helps people walk normally after stroke or injury.
GN Hearing is working with Google to adapt its devices to communicate seamlessly with Android smartphones.
Imaging giant will complement Imris' design of surgical suites.
Fee is St. Paul firm's share in a court settlement over price-fixing allegations against major dental suppliers.
UnitedHealth has said that transforming pharmacy care services is a key goal it hopes to accomplish.
Startup is using University of Minnesota technology to develop a balloon device to treat pulmonary hypertension.
Valve trial showed patients less likely to end up in the hospital and had lower risk of death.
Results were rolled out at an industry conference.
Using robotic-assisted equipment can improve precision, lessen complications.
A label change could expand the market for the device maker's CoreValve Evolut system.
Recalled ICD devices made at Puerto Rico facility had potential electrical flaws.
As a lover of history, Jules Smith also was fascinated with the new, playing a key role in the founding of a first-of-its-kind community in…
Developed at the U, the jaw-fixation system uses less-invasive zip-ties that can be removed quickly and without surgery
Industry, officials work to boost security of medical devices.
The St. Paul firm is developing a product that removes contaminants in the cerebral spinal fluid after a hemorrhagic stroke.
Sales of Augmenix's SpaceOAR hydrogel are projected to nearly double in the next year.
The nonprofit will focus on older drugs that have become scarce and pricey.
The State Fair broke an all-time attendance record Saturday, with 270,426 people walking through its gates. Sunday's attendance figure wasn't immediately available, but by Monday, the fair could easily meet or even break its overall attendance record and hit the 2 million mark.
As liver diseases grow, the noninvasive scan provides an alternative to a biopsy.
Class action's plaintiffs say executives knew $50 billion deal would cost shareholders.
Plymouth-based medical technology startup Urotronic has raised $20 million in its effort to invent a better way to treat urethral problems.A joint venture of Hillhouse…
By injecting money early in the game, they hope to groom the next big product.
Medtronic's popular medical devices power strong quarterly results.
Devices can reset heart rhythms without using wires in the heart.
IRS officials say the company has shifted income on paper to lower its tax bill.
Critics say company has been slow to act on medical devices' cybersecurity vulnerabilities.
The device, to be made by St. Paul-based Minnetronix, gives doctors a clearer view of how a heart surgery is going.
Takeda hopes to begin making its Entyvio drug for bowel diseases at its Brooklyn Park plant next year
Hackers a persistent threat to patient safety, demanding vigilance.
Focus is on long-term value, cost of pumps and monitors.
Company maintained its financial guidance for year.
The device maker denies the allegations made against Infuse product.
California firm makes device that aims to reduce post-operation strokes.
Strong growth for its diabetes unit was key to driving second quarter earnings that exceeded expectations.
About 39,000 defibrillators and pacemakers are affected by what regulators have classified as a Class 2 recall.
Early study results of 6,000 diabetic patients showed a drop in hospital visits.
Media blitz aims to boost support for a repeal.
Abbott advises patients to get updates at next scheduled doctor visit.
Following tumult in the 1960s and '70s, Bob's sobriety in the 1980s became an example for others.
The California company is developing a treatment for atrial fibrillation.
CEO is setting up shop in Twin Cities, looking to grab part of $20 billion market.
Mpls.-based firm pursuing Boston company's biopsy-free cancer detection tech.
More from Star Tribune